Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study Using Nexalin Therapy for the Treatment of Depressive Symptoms Associated With Mild to Moderate Depression Episodes

NCT00774813 is registered in ClinicalTrials.gov with Kalaco Scientific, Inc. as lead sponsor.

NCT NCT00774813
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00774813 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study Using Nexalin Therapy for the Treatment of Depressive Symptoms Associated With Mild to Moderate Depression Episodes
Lead sponsor
Kalaco Scientific, Inc.
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2007
Completion date
May 31, 2008
Enrollment
120 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

depression